首页> 外文期刊>Der Pharmacia Lettre >Formulation preparation, characterization, optimization, behavior and histological evaluation of brain hippocampus for brain targeted PLGA-Soya lecithin-Tween 80 nanoparticles in an Alzheimera??s disease model
【24h】

Formulation preparation, characterization, optimization, behavior and histological evaluation of brain hippocampus for brain targeted PLGA-Soya lecithin-Tween 80 nanoparticles in an Alzheimera??s disease model

机译:在阿尔茨海默氏病模型中针对脑靶向PLGA-大豆卵磷脂-吐温80纳米粒子的脑海马的制剂制备,表征,优化,行为和组织学评估

获取原文
           

摘要

In present study, we formulated RT loaded PLGA-Soya lecithin-Tween 80 NPs, for the treatment of Alzheimer’s disease (AD). After formulation we optimized formulation by Response Surface Methodology (RSM) using 32 factorial design. PLGA-Soya lecithin-Tween 80 nanoparticles were synthesized by modified nanoprecipitation technique combined with self assembly. Influence of important factors on the particle size, polydispersity, entrapment efficiency and in vitro drug release were studied. FTIR and DSC studies demonstrated that there was no interaction between drug, polymers and lipid and they were compatible with each other. Prepared nanoparticle of optimized formulation (D10) showed particle size 171.74 nm, polydispersity 0.154, entrapment efficiency 66.171 % and in vitro drug release 67.336 ± 0.254% (60h). Zeta Potential and stability study for six months demonstrated that the formulations were stable at refrigerator (3-5°C) condition is most suitable for storage of nanoparticles. SEM studies results indicated that the NPs were spherical in shape and smooth at surface. In vivo behavioral studies, AchE activity analysis and histological study of hippocampus demonstrated that, the rats treated with NPs showed markedly better memory retention and better brain condition compare to pure drug treated. The study demonstrated the successful attempt to target brain with RT loaded PLGA-Soya lecithin-Tween 80 NPs, with considerable therapeutic prospective to treat AD and potential carrier for providing sustained brain delivery of RT.
机译:在本研究中,我们配制了RT负载的PLGA-大豆卵磷脂-吐温80 NP,用于治疗阿尔茨海默氏病(AD)。配制后,我们使用32因子设计通过响应表面方法(RSM)优化了配方。通过改进的纳米沉淀技术结合自组装合成了PLGA-大豆卵磷脂-吐温80纳米颗粒。研究了重要因素对粒径,多分散度,包封率和体外药物释放的影响。 FTIR和DSC研究表明,药物,聚合物和脂质之间没有相互作用,并且它们彼此相容。制备的优化配方(D10)的纳米颗粒的粒径为171.74 nm,多分散性为0.154,包封率为66.171%,体外药物释放为67.336±0.254%(60h)。六个月的Zeta电位和稳定性研究表明,该制剂在冰箱(3-5°C)条件下稳定,最适合纳米颗粒的存储。扫描电镜研究结果表明,纳米颗粒呈球形,表面光滑。体内行为研究,AchE活性分析和海马组织学研究表明,与纯药物治疗相比,NPs治疗的大鼠显示出明显更好的记忆保持能力和更好的大脑状况。这项研究证明了使用负载RT的PLGA-大豆卵磷脂-吐温80 NP靶向大脑的成功尝试,具有相当的治疗前景,可以治疗AD和潜在的载体,以提供持续的RT大脑递送。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号